CELCUITY INC. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
CELCUITY INC. (CELC) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $38.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-03-26
- CELCUITY INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was $38.25M, a 60.73% increase from fiscal 2024.
- CELCUITY INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2024 was $23.80M, a 75.73% increase from fiscal 2023.
- CELCUITY INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2023 was $13.54M, a 41.91% increase from fiscal 2022.
- CELCUITY INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2022 was $9.54M, a 50.76% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $38.25M 10-K · filed 2026-03-26 | |
| 2024-12-31 | $23.80M 10-K · filed 2026-03-26 | $24.08M 10-K · filed 2025-03-31 |
| 2023-12-31 | $13.54M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $9.54M 10-K · filed 2024-03-27 | |
| 2021-12-31 | $6.33M 10-K · filed 2023-03-23 | |
| 2020-12-31 | $2.16M 10-K · filed 2022-03-23 | |
| 2019-12-31 | $1.78M 10-K · filed 2021-02-16 | |
| 2018-12-31 | $1.88M 10-K · filed 2020-03-13 | |
| 2017-12-31 | $897.00K 10-K · filed 2019-03-01 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |